| Health / Medical Topics |
Nivolumab
Pronunciation
A fully human monoclonal antibody directed against the negative immunoregulatory human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1/PCD-1) with immunopotentiation activity. Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands PD-L1 and PD-L2, resulting in the activation of T-cells and cell-mediated immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and effector function through the suppression of P13k/Akt pathway activation. (NCI Thesaurus)
YOU MAY ALSO LIKE
A country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga and south of American Samoa. …
A naturally occurring gas that is colorless and non flammable. It can be manufactured and used for a variety of things such…
Any of a class of alkylating agents that contain both a nitroso group and a urea. They are lipophilic and can cross…
An anticancer drug that can cross the blood-brain barrier. Carmustine and lomustine are nitrosoureas.
A yellow, oily liquid nitrosamine that solidifies at cold temperatures and emits toxic fumes of nitrogen oxides when heated to decomposition. Nitrosonornicotine…
A yellow, liquid nitrosamine that rapidly degrades in the presence of light and emits toxic fumes of nitrogen oxides when heated to…
